Bausch Health (NYSE: BHC) EVP receives RSU grant, tax shares withheld

Rhea-AI Filing Summary

Bausch Health Companies Inc. executive Aimee J. Lenar reported equity compensation changes in company common shares. She received a grant of 157,139 restricted share units at $0.0000 per share on February 25, 2026, increasing her direct holdings to 417,913 shares.

These RSUs vest one-third on each of the first three anniversaries of the grant date, contingent on continued service, and are settled in common shares. On February 26, 2026, 17,578 common shares valued at $6.04 per share were withheld to cover tax obligations upon RSU vesting, leaving her with 400,335 directly held shares.

Insider Trade Summary

Net Buyer: 139,561 shares

Net Buy 2 txns

Insider Lenar Aimee J.

Role EVP, US Pharma

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Shares, No Par Value	17,578	$6.04	$106K
Grant/Award	Common Shares, No Par Value	157,139	$0.00	$0.00

Holdings After Transaction: Common Shares, No Par Value — 400,335 shares (Direct)

Footnotes (2)

1. F1. Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
2. F2. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/27/2026 - 05:21 PM Learn about SEC filing dates

FAQ

What equity transactions did BHC executive Aimee J. Lenar report on this Form 4?

Aimee J. Lenar reported a grant of 157,139 restricted share units and a withholding of 17,578 common shares. The withholding covered tax obligations upon RSU vesting, and both transactions involved Bausch Health common shares held directly by her.

How many Bausch Health (BHC) RSUs were granted to Aimee J. Lenar?

She was granted 157,139 restricted share units at a stated price of zero per share. These units vest in three equal annual installments and are settled in Bausch Health common shares if service conditions are satisfied through each vesting date.

What is the vesting schedule for Aimee J. Lenar’s BHC restricted share units?

The restricted share units vest one-third on each of the first three anniversaries of the grant date. Vesting is conditioned on Aimee J. Lenar’s continued service, and vested RSUs are settled in Bausch Health common shares with no par value.

Why were 17,578 Bausch Health (BHC) shares withheld from Aimee J. Lenar?

The 17,578 common shares were withheld to satisfy tax withholding obligations triggered when restricted share units vested. This tax-withholding disposition is reported under transaction code F and reduced her directly held Bausch Health common shares accordingly.

How many Bausch Health common shares does Aimee J. Lenar hold after these transactions?

After the RSU grant and subsequent tax-withholding share disposition, Aimee J. Lenar directly holds 400,335 Bausch Health common shares. This figure reflects the net position following the 17,578 shares withheld for tax obligations tied to RSU vesting.

Did Aimee J. Lenar buy or sell Bausch Health (BHC) shares on the open market?

The reported transactions consist of an equity award and tax-withholding share disposition, not open-market trades. The RSUs were granted as compensation, and the 17,578 shares were withheld solely to cover tax obligations associated with RSU vesting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lenar Aimee J.

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD.

(Street)

BRIDGEWATER NJ 08807

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, US Pharma

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	02/25/2026		A		157,139(1)	A	$0	417,913	D
Common Shares, No Par Value	02/26/2026		F		17,578(2)	D	$6.04	400,335	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.

2. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

	/s/ Brianna M. Dorsi attorney-in-fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.